#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital absence of bile ducts Hodgkin's disease Adenoid cystic carcinoma HER2 mutant non-small cell lung cancer Breast angiosarcoma metastatic Salivary gland cancer Prostate cancer Hypertriglyceridaemia Wolfram syndrome Infection in an immunocompromised host Retinal dystrophy Mucopolysaccharidosis II Adult T-cell lymphoma/leukaemia refractory Mucous membrane pemphigoid Oropharyngeal cancer recurrent More trials…

    Learn about Rare Diseases

    Chondrosarcoma Ewing’s sarcoma – Life with Disease Combined immunodeficiency – Basic Information Glomerulonephritis rapidly progressive – Life with Disease Lysosomal storage disorder – Basic Information Breast angiosarcoma metastatic – Diagnostics Lysosomal storage disorder – Life with Disease Marfan’s syndrome – Trials in Disease Activated PI3 kinase delta syndrome – Life with Disease Mantle cell lymphoma stage III – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Canakinumab Gentamicin AMMONIUM (15N) CHLORIDE Chlorhexidine Gluconate Alx148 Psma-11 Setanaxib Treprostinil Teclistamab Pilocarpine Nitrate Dolutegravir Sodium Carcik-Cd19 Cells Tpst-1120 Metronidazole Esomeprazole Magnesium Db-Oto-3 Alternaria Alternata (402) GSK5784283 USNOFLAST Azithromycin More therapies…

    Learn about Your Condition

    Skin neoplasm excision Burning mouth syndrome Morning sickness Rectal neoplasm Merycism Optic ischaemic neuropathy Premature rupture of membranes Endocarditis enterococcal Osteoarthritis Corneal graft rejection Carotid arteriosclerosis Gastrooesophageal cancer Cutaneous lupus erythematosus Electrocorticogram Aortic valve disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Dostarlimab for Patients with Advanced or Metastatic Non-Colorectal/Non-Endometrial Cancer with dMMR/MSI, Compared to Standard Drug Combination

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Trabectedin
    • Ifosfamide
    • Mitotane
    France

  • Study on Preventing Infections After Esophageal Cancer Surgery Using Colistin Sulfate, Tobramycin, and Amphotericin B in Patients with Resectable Esophageal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    Investigated Drugs:
    • Nystatin
    • Tobramycin
    • Colistin Sulfate
    Belgium The Netherlands

  • Study on Beta-Blockers for Patients with Takotsubo Syndrome: Evaluating Selective, Non-Selective, and Alpha-Beta Blocking Agents

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Stress cardiomyopathy
    • Cardiac failure acute
    Spain

  • Oxygen Therapy for Pregnant Women to Support Heart Development in Unborn Babies with Underdeveloped Left Heart Structures

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Oxygen
    Germany

  • Study Comparing Lithium and Lamotrigine for Mood Stabilization in Patients with Bipolar Disorder Type II

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Lithium Carbonate
    • Lamotrigine
    Denmark

  • Study of LN-145 (Tumor Infiltrating Lymphocytes) in patients with metastatic non-small-cell lung cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    • Non-small cell lung cancer
    Investigated Drugs:
    • Autologous Tumour-Infiltrating Lymphocytes
    • Aldesleukin
    • Fludarabine Phosphate
    Belgium France Germany Italy The Netherlands Spain
Previous Page
1 … 454 455 456 457 458 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!